To The Moon

You are framing the right tension. In this setup, the “beat” matters far less than the forward signal. 1) What actually drives price now For large banks like Citigroup, Wells Fargo, and Morgan Stanley: Q1 numbers = backward-looking Trading + deal fees tend to be cyclical and already visible via market activity Net interest income (NII) is largely modelled ahead of time Guidance = repricing catalyst 2026 NII trajectory (rate cuts vs stickiness) Investment banking pipeline (is deal momentum durable?) Credit quality (early stress signals matter more than beats) 👉 In this environment, guidance > beat, unless the beat is materially outside expectations. --- 2) Market positioning matters more than the print Right now the market is: Already expecting “solid” quarters Positioned for stabilising

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

Who’s winning the oral weight-loss drug race? The GLP-1 weight-loss market is shifting from injectables to oral pills — and it’s still Novo vs. Lilly at the top. Which giant has stronger long-term momentum? Let’s break it down clearly. The weight-loss drug race is moving from the injectable first half to the oral second half. Late last year, the first oral GLP-1 weight-loss drug was approved, and analysts project the market will near $100 billion by 2030. At the table are the same two giants: Denmark’s Novo Nordisk (NVO) and U.S. star Eli Lilly (LLY). In the injectable era, Lilly overtook the market with superior efficacy from tirzepatide (Mounjaro/Zepbound) and aggressive production expansion, capturing 60% of the U.S. market. Now the battlefield has shifted to oral drugs. Can Novo Nordis

Most people still think of SanDisk as the little USB drive in their desk drawer. The market has a very different view now. SNDK soared 9.05% to $851.57 on April 10, touching an intraday high of $855 to set a fresh all-time record. That extends one of the most extraordinary runs in semiconductor history. From a post-spinoff panic low of $27.89 on April 7, 2025, the stock has returned 30x in exactly twelve months. A $10,000 position at last year's low is worth $305,500 today. MU followed, climbing 3.63% to $421.51 for a third consecutive session with a cumulative 14% gain. The storage bull run is accelerating. Here is everything behind it, and the critical question: how much further can it go? 🏭 The New SanDisk You Need to Understand This is not the thumb drive company anymore. SanDisk separ

The AI Inference boom is now driving demand across the full compute stack from silicon & memory to optics, power, packaging & cloud: • AI Silicon: $NVIDIA(NVDA)$, $Advanced Micro Devices(AMD)$, $Broadcom(AVGO)$, $Intel(INTC)$ • Foundry & Packaging: $Taiwan Semiconductor Manufacturing(TSM)$, $Amkor Technology(AMKR)$, $GLOBALFOUNDRIES Inc.(GFS)$ • Memory & Storage:

Current Market Position: Gold prices are stuck in a "can't fall, can't rise" pattern within the $4700-$4800 range. On the daily chart, the MACD histogram continues to expand, indicating strong bullish momentum. However, the KDJ indicator's J value has entered a strong zone and is approaching overbought territory, suggesting a short-term need for consolidation. The 4-hour chart shows short-term moving averages turning downwards, with the price trading below the MA5/MA10. The MACD has turned from red to green, and the green histogram is gradually increasing in volume, indicating emerging bearish momentum. Key Price Levels for Bulls and Bears$Gold - main 2606(GCmain)$ Level | Direction | Price (USD/oz) | Explanation: Premium Resis

Hello everyone! Today i want to share some trading ideas with you! 1 From early February into the end of March, we watched $S&P 500(.SPX)$ drop nearly 700 points. Every week felt worse than the last. Retail kept trying to buy every dip and got chopped up. By the time we bottomed, sentiment was at max fear. No confidence, no hope. And we bottomed around the same time as 2025… in April. Now flip it. When $S&P 500(.SPX)$ reclaims 7000, you’re going to see the same emotion… just in the opposite direction. Doubt, fear mongering, people calling tops the entire way up into 7700–8000. Traders will try to short when they should be going long. And most will miss the move. Whe

Market breadth is weakening as momentum cools. $SPX participation is rolling over, while $SMH points to a healthy consolidation phase. At the same time, $TSLA sits at key long-term support and $PLTR shows a potential bullish reversal signal. The market may be shifting from trend to consolidation, with selective setups emerging. 1. $S&P 500(.SPX)$ The percentage of stocks above their 20DMA has reversed from 70%, usually a consolidation follows; this time potentially below the 50DMA. The market was driven by strength in Tech and Materials, overall participation was negative. 2. $VanEck Semiconductor ETF(SMH)$ Two weeks ago I posted in my publication that semiconductors would outperform the market at the

An IPO used to be the start of a new era for companies. $Apple(AAPL)$ IPO’d four years after it was founded in 1980 with a $1.8 billion valuation. $Microsoft(MSFT)$ went public in 1986 as a relatively mature 11-year-old company with a $777 million valuation. $Amazon.com(AMZN)$ went public three years after it was founded in 1997 with a $438 million valuation. $Alphabet(GOOG)$ went public six years after its founding at a $23 billion valuation. It used to be the case that companies would go public because they needed money on a scale that only public markets could offer. And in some cases it was a way to unlock value for

Strong week, profits secured. $AMD targets hit, $NBIS extended higher — but $SPY is now at a bearish zone with macro risk ahead. Focus shifts to protecting gains, not chasing upside. 1. $Advanced Micro Devices(AMD)$ $AMD target hit 🎯 Locking in profits on calls and shares here. No reason to get greedy into the weekend in case we see a rejection. 2. $NEBIUS(NBIS)$ $NBIS +40% since our Combined Signal System buy We called this setup last week. Congrats if you took it I passed since I haven’t profited on prior moves this cycle That said, last 2 callouts in 2 months have printed 60%+ 🔥 3. $SPDR S&P 500 ETF Trust(SPY)$ $SPY at a bearish smart money zone into the wee

In the early days of AI, we saw the rise of “GPT Wrappers.” Companies that created a product that resembled a thin layer on top of a model. People loved to mock these products, saying all the value was in the model with everything around it commoditized. “Why would I use your app when I can just use ChatGPT directly?” Years later, we have a new name for “wrapper” which is now “harness.” OK that’s a crude analogy and not exactly apples to apples... a harness is really the code that determines what information a model sees at each step, what to store, what to retrieve, and what context to present. It’s the scaffolding around the model. But the spirit of the comparison is directionally right: there’s an enormous amount of value in what sits around the model, not just the model itself. And we

Two weeks ago this publication anticipated the high probabilities for a reversal given extreme oversold conditions. Back then, the price action was extremely oversold and sentiment was at lows not seen since the previous crash in April 2025. When the market began its bounce on March 31, essential levels were reclaimed. First, the Central Daily Level (our “Bullish Above / Bearish Below” indicator) sat at 6,362. The price opened above this level, providing an immediate bullish signal to subscribers who use our levels for validation. Subsequently, our Central Weekly Level (CWL) of $6,458 “sealed the deal,” confirming the weekly reversal and validating the bullish setups for the $SPDR S&P 500 ETF Trust(SPY)$ $S